Our rationale for limiting these analyses to participants with normal cognition and with MCI was that people ultimately destined to develop AD should have greater rates of decline in cognition in general and memory in particular than people not destined to develop AD, but that the AD CSF profile might not have a relationship with subsequent trajectories of cognition among people with established A